Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.69 |
| ▸ | MAG | P20916 | 6/20 | 0.63 |
| ▸ | SELL | P14151 | 1/20 | 0.63 |
| ▸ | SELP | P16109 | 1/20 | 0.63 |
| ▸ | CD22 | P20273 | 6/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL804936 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL29412465 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL30001019 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL29405239 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL14362275 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL19922284 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL24628357 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL30185416 | 0.98 | SIGLEC7 (0.66) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL31700860 | 0.97 | SIGLEC7 (0.68) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL30970760 | 0.97 | SIGLEC7 (0.70) | SIGLEC7MAGSELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216406-A1 | METHODS AND COMPOSITIONS FOR SUPPORTING HUMAN HEALTH DURING SPACE TRAVEL | INTRINSIC MEDICINE INC (US) | 2024-07-04 | — | — | US | disclosed |
| US-20220218727-A1 | METHODS AND COMPOSITIONS OF SUPPORTING HUMAN HEALTH DURING SPACE TRAVEL | INTRINSIC MEDICINE, INC. | 2022-07-14 | — | — | US | disclosed |
| US-20220193099-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF PAIN | TARGET CAPITAL 4 LLC | 2022-06-23 | — | — | US | disclosed |
| WO-2011100979-A1 | PRODUCTION OF 6'-O-SIALYLLACTOSE AND INTERMEDIATES | GLYCOM A/S (DK) | 2011-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193099-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF PAIN | FUT6, CSGALNACT1, FUT5 | SIGLEC7 19/4885MAG 24/4885SELL 142/4885 |
| US-20240216406-A1 | METHODS AND COMPOSITIONS FOR SUPPORTING HUMAN HEALTH DURING SPACE TRAVEL | FUT6, FUT5, FUCA2 | SIGLEC7 195/4885MAG 489/4885SELL 709/4885 |
| US-20220218727-A1 | METHODS AND COMPOSITIONS OF SUPPORTING HUMAN HEALTH DURING SPACE TRAVEL | FUT6, FUT5, FUCA2 | SIGLEC7 195/4885MAG 525/4885SELL 655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.